Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Manford AG, et al
Table 2 Overview of the SURPASS clinical trial program with tirzepatide in the therapy of type 2 diabetes
Session length depends on the protocol
Hoeppner MP, Lundquist A, Pirun M, Meadows JR, Zamani N, Johnson J, et al
Gastrointestinal effectsparticularly nausea, vomiting, diarrhea, and constipationaffect 40-50% of patients, especially during dose escalation
US$ 25.34
US$ 21.02
US$ 20.63
US$ 24.96
US$ 24.38
US$ 24.84
US$ 24.38
US$ 20.30
US$ 20.66
